-
BHEL successfully commissioned the Telangana hydropower project
Time of Update: 2022-12-28
:/, please indicate the source for reprinting)Recently with the commissioning of the fourth and final 30 MW hydroelectric generating unit, Bharat Heavy Electric Co.
:/, please indicate the source for reprinting)/ It is understood that three other 4x30 MW Pulichintala HEP units commissioned earlier by BHEL have already been successfully operational.
-
The first batch of wind turbines of Anhui Hanshan Zhaoguan Wind Power Project were connected to the grid for power generation
Time of Update: 2022-11-19
Wind power projects In October, the construction of the wind power project entered the final stage, in order to seize the construction period affected by the rainy weather, and do a good job in the final project defect elimination work to rush to power generation, construction workers 24 hours in shifts construction, all construction management personnel arrived at the site at 4 a.
-
Guangzhou Petrochemical sold 253 tons of high-purity hydrogen in the first half of the year
Time of Update: 2022-11-04
Since the center was put into operation, a total of 470 tons of high-purity hydrogen has been supplied, which has helped the rapid development of the hydrogen energy industry in the Guangdong-Hong Kong-Macao Greater Bay Area.
-
The total investment is 23.1 billion
Time of Update: 2022-10-18
Overview of the high-performance new material integration project in Wanhua Penglai Industrial ParkMain project: a new 900,000 t/a propane dehydrogenation unit, a 400,000 t/a propylene oxide unit, a 300,000 t/a ethylene oxide unit, and a 300,000 t/a polypropylene unit equipment, a set of acrylic acid and ester equipment (160,000 t/a acrylic acid equipment, 160,000 t/a butyl acrylate equipment, 20,000 t/a octyl acrylate equipment), a set of 500,000 t/a polyether equipment, a Sets of 300,000 t/a EOD devices .
-
Science is another masterpiece! The latest Nobel laureate Pääbo has collaborated to uncover the differences between modern humans and Neanderthals' neocortex of the brain
Time of Update: 2022-10-13
By overexpressing in the neocortex of developing mice and ferrets, knocking out in fetal human neocortex tissue, and genome-edited brain organoids, the study found that the modern human variant, hTKTL1, rather than the Neanderthal variant, increased the richness of basal radial radial glial cells (bRG) but not the richness of intermediate progenitor cells (bIPs).
-
Professor Jianguo Wu of PLoS Pathog has made new progress in the study of the mechanism of interferon regulation in influenza viruses
Time of Update: 2022-09-21
" infection”。 This study reveals a new mechanism for influenza A virus (IAV) infection, which regulates type I interferon synthesis through the host sphingosine kinase SPHK2 and thus affects viral replication.
-
China Construction Third Engineering Bureau Zhengzhou Metro Line 4 Project launched the "Thanksgiving Chongyang Inheriting Filial Piety" activity
Time of Update: 2022-09-18
News from this magazine (Reporter Wei Hongkui Correspondent Ye Tuanwei) On the morning of October 7th, on the day of the Double Ninth Festival on September 9, the Party Branch of the Zhengzhou Metro L
-
Yanchang Yuneng Chemical's ground torch reconstruction was successful
Time of Update: 2022-09-07
On August 28, with the start-up of the first line of the methanol-to-olefins plant, the process flare gas of the ground flare receiving device of China Coal Yu Neng Chemical Company was extended, which solved the environmental pollution caused by the "black smoke burning" of the overhead flare during the start-up and shutdown of the plant.
-
The first phase of Meide Petrochemical Propane Dehydrogenation PDH Project is handed over
Time of Update: 2022-08-24
, a subsidiary of China Flexible Packaging Group, held a handover ceremony, marking that the project has entered the trial run stage and is about to achieve commercial operation Today, the first phase of the propane dehydrogenation PDH project of Fujian Meide Petrochemical Co.
-
Due to an authorization transaction, the half-year performance forecast of this pharmaceutical company was revised to over 800 million yuan
Time of Update: 2022-08-15
363 billion in milestone payments and royalties on post-market net sales) licensed to Merck It is understood that this authorization transaction took place on May 13, when Colombo and Merck signed an agreement to pay a down payment of US$47 million for the rights outside Greater China of the biological macromolecular tumor project A with independent intellectual property rights ( and up to $1.
-
Zhou Yue's group published a paper in The Plant Cell to reveal the chromatin remodeling complex
Time of Update: 2022-05-11
On April 22, 2022 , Zhou Yue's research group from the State Key Laboratory of Protein and Plant Gene Research, the School of Modern Agriculture of Peking University, and the Peking University-Tsinghua University Life Science Joint Center published an online article entitled "Chromatin remodeling complexes" on The Plant Cell .
-
Clin Cancer Res: Long-term outcomes of second-line nivolumab in advanced esophageal cancer
Time of Update: 2022-04-24
Nivolumab has a long-term overall survival advantage over chemotherapy as second-line therapy for previously treated advanced esophageal cancer .
Nivolumab has a long-term overall survival advantage over chemotherapy as second-line therapy for previously treated advanced esophageal cancer .
-
Tianhua ultra-net fundraising to expand lithium hydroxide production capacity
Time of Update: 2022-03-04
Phase I project with an annual output of 25,000 tons of battery-grade lithium hydroxide, acquisition of 7% equity of Yibin Tianyi Lithium Industry Science and Technology Co.
-
Two Nature papers in the same period: The replication and pathogenic ability of Omicron mutants are reduced
Time of Update: 2022-02-20
In laboratory experiments on human lung and intestinal epithelial cells, the authors found that the replication capacity of live Ormicon virus was compared with the new coronavirus wild-type and Alpha, Beta and Delta changes.
-
Ruike Biotechnology obtained the New Crown Vaccine "Drug Production License" issued by the Jiangsu Provincial Food and Drug Administration
Time of Update: 2021-12-07
The new crown vaccine and adjuvant production base established by Ruike Biotech in Taizhou, Jiangsu Province is constructed in accordance with the current international GMP standards.
